Anthem Blue Cross and Blue Shield (Anthem) recently updated the Claim Inquiry/Adjustment Filing Tips section of our online Provider Manual. The update includes information on functionality to submit medical records requested by Anthem via Availity that was not available when the 2018 Provider Manual was originally posted. More detailed information on this functionality can be found in the August 2018 Network Update Newsletter. The updated manual is available on our public provider website at anthem.com. Select Providers under Partners in Health. On the Provider landing page, select Find Resources for Your State, select Indiana. On the Provider home page, select the Communications menu, then Publications.  If you have questions, please contact your local Network Relations Consultant at 1-800-455-6805.

Continuing to build on the initial launch of the new public provider pages, Anthem Blue Cross and Blue Shield (Anthem) recently released a brand new, redesigned landing page for Provider Resources. The most recent release also includes a new Communications page with a clear and concise access point for Newsletters and eUpdates, as pictured below.



This October, anthem.com will be introducing exciting changes to the public provider site. Coming in the next wave of changes, providers can anticipate a new landing page for manuals and an improved, streamlined experience for Reimbursement Policies.

We will continue to keep you informed on upcoming changes to the public provider site as we progress toward streamlining our web platform and other business processes.

Who is Availity?

Most of you know Availity as web portal or claims clearinghouse, but they are much more.  Availity is also an intelligent EDI Gateway for multiple vendors and will be the EDI connection for all Anthem Inc. and its affiliates.

If you currently use a clearinghouse, billing company or if you submit directly, all your EDI transactions will flow through the Availity EDI Gateway to Anthem.

How are you submitting EDI transactions today?

• If you currently transmit your EDI Submissions using a clearinghouse or Billing Company, you should contact your clearinghouse to confirm your EDI submission path has not changed.
• If you are notified of any potential impacts with connectivity, workflow or financial, please know there is no cost alternate submission options available with Availity.
• If you currently submit directly to Anthem and already have an Availity login for the portal, you can use that same login for your EDI services.
• Please visit https://apps.availity.com/web/welcome/#/anthem to learn more.

How can you directly transmit EDI submission to Availity?

Below are the different ways you can submit direct EDI transactions to Availity:

• Submit transaction files through FTP - If you work with a practice management system, health information system, or other automated system that supports an FTP connection, you can securely upload EDI transactions to the Availity FTP site where they are automatically picked up by Availity and submitted to Anthem
• Submit transaction files through the Availity Portal - If you have batch files of EDI transactions that you need to process and you choose not to use the Availity FTP site, you can manually upload the batch files through the Availity Portal.
• Submit transactions through manual data entry in the Availity Portal - The Availity Portal makes it easy to submit transactions, such as eligibility and benefits inquiries or claims, by entering data into our user-friendly web forms.

What are your next steps?

• It may take time to work with your clearinghouse or billing company, so please take action now to help ensure continuity of your EDI transactions.
• If you choose to submit direct, we recommend that you register with Availity for your EDI transmissions and begin migrating your volume by the end of 2018 by visiting this URL- https://apps.availity.com/web/welcome/#/anthem
• The EDI transactions include the 837, 835 and 27X (eligibility and claim status).
• Availity will be working directly with your Clearinghouse, Billing Companies or your organization if you choose to submit directly.

We look forward to delivering a smooth transition to the Availity EDI Gateway. If you have any questions please contact Availity Client Services at 1-800-Availity (1-800-282-4548) Monday through Friday 8:00 a.m. to 7:30 p.m. Eastern Time. 

Check out this webinar for lots of great information to get you started. At the end of the training, you can participate in a live Q&A session. During this fast paced hour, learn how to:

• Understand Availity’s EDI Gateway and Clearinghouse workflow for 837, 270/271, 276/277, and 835 transactions.
• Use the Availity Portal to manage file transfers, set up EDI reporting preferences, manage your FTP account, and more.
• Enroll for and manage 835 ERA delivery with Availity.
• Access and navigate the Availity EDI Guide.
• and more….

Upcoming Sessions

Currently scheduled upcoming sessions include:

• October 29, 2018, 1:00 p.m. – 2:00 p.m. ET
• November 7, 2018, 11:00 a.m. – 12:00 p.m. ET

Enroll

1. Log in to the Availity Portal.
2. Select Help and Training > Get Trained.
3. In the Availity Learning Center (ALC) Catalog, select Sessions.
4. Scroll Your Calendar to find and enroll for a live session.

Can’t make it?

We’ve got you covered with a recording of a previous live session. In the ALC, search the Catalog by keyword (song) and enroll for the on-demand option.

Need Help?

Email training@availity.com if you have issues enrolling for a live webinar.

The Communication and Education section includes two new categories to help make it easier for you to find what you need: Payer Spaces and Interactive Care Reviewer. 

With an Availity log in you can easily view any new content added to the ERC. There is no additional role assignment needed.

Find the ERC on the Availity Portal under Payer Spaces / Anthem / Applications. If you are having trouble locating the Education and Reference Center, type Education and Reference Center in the Availity Search option located on the top navigation menu. Select the heart next to the application to save it to your Favorites.

As part of Anthem’s role to safeguard our members and provide relevant information to providers we are relaying the following recent Food and Drug Administration (FDA) Warning Letters:  

Estring - On June 19, 2018 the Food and Drug Administration issued a letter of warning to Pfizer for “false or misleading” promotional materials related to ESTRING® (estradiol vaginal ring).  According to the FDA the posted “… video is especially concerning from a public health perspective because it fails to include any risk information about Estring, which is a drug that bears a boxed warning due to several serious, life-threatening risks, including endometrial cancer, breast cancer, and cardiovascular disorders, as well as numerous contraindications and warnings. The video thus creates a misleading impression about the safety and efficacy of Estring”.

Xtampza ER –-On February 9, 2018 the Food and Drug Administration issued a letter of warning to Collegium Pharmaceuticals for publicly providing false or misleading representations regarding Xtampza (oxycodone) ER because it “fails to adequately communicate information about the serious risks associated with Xtampza ER use”.

Further details regarding these Warning Letters from the FDA can be obtained from the FDA website:

• Information about Estring
• Information about Xtampza ER

This is the seventh year for our incentive program to acknowledge some of our providers who either responded in a timely manner or went “Above and Beyond” to help make our HEDIS data collection successful. Any practices that responded within five business days of our initial request or who went out of their way by taking additional steps to help us with data collection were entered in a drawing to receive a gift. We are pleased to announce that our incentive winners are as follows:

HEDIS Drawing Winners

• Central Indiana Podiatry PC
• Hazel Dell Family Care
• Cornerstone Family Physicians PC
• Joshi Pediatrics
• IU Heath Physicians Primary Care Methodist Eagle Highlands - Dr. LaRosa

• Indiana University Health/Revenue Cycle Services
• Parkview Randallia Hospital, Release of Information
• St. Catherine Hospital
• St. Vincent Medical Group/St. Vincent Parkwood West

Our HEDIS results reflect the care you provide to our members. Now is the time to review your patient’s records to ensure that they have received their preventative care and/or immunizations before the end of the year.

An overview of our HEDIS rates will be published in the 4th quarter provider newsletter. In addition more information on HEDIS can be found by visiting the provider portal at: www.anthem.com and select Provider, then Indiana, then Health & Wellness,  then Quality Improvement and Standards, then HEDIS Information.

Thanks again to all of our provider offices and their staff for assisting us in collecting HEDIS data. We look forward to working with you next HEDIS season!

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Through the use of compelling real-life stories that convey practical strategies for implementing patient care, providers learn how to apply best practices.

Did you know?

• Substantial evidence points to a positive association between the patient experience and health outcomes.
• Patients with chronic conditions, such as Diabetes, demonstrate greater self-management skills and quality of life when they report positive interactions with their health care providers.
• Patients reporting the poorest-quality relationships with their physicians were three times more likely to voluntarily leave the physician's practice than patients with the highest-quality relationships.

How will this benefit you and your office staff?  You’ll learn tips and techniques to:

• Improve communication skills.
• Build patient trust and commitment.
• Expand your knowledge of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey.

The course can be accessed at www.patientexptraining.com using your smartphone, tablet, or computer.

Like you, Anthem is committed to improving the patient experience in all interactions, and we are proud to work collaboratively with our provider network to provide support and tools to reach our goal.

Take the course today!

Effective October 14, 2018, Anthem BCBS will enforce the requirement to bill the correct modifier and HCPCS for services utilized.  Incorrect billing will be rejected and claims will be returned to the provider for correction and resubmittal.

Durable Medical Equipment (DME) may be purchased, rented or rented until the purchase price has been paid. 

Correct billing will allow member benefits to be applied correctly to include benefit accumulations for a member’s DME benefits.

Advanced imaging appropriate use criteria: Imaging of the heart

Effective for dates of service on and after January 28, 2019, the following updates will apply to the AIM Specialty Health© (AIM), a separate company, clinical appropriateness guidelines: advanced imaging appropriate use criteria: imaging of the heart:

Carotid duplex ultrasound

• Criteria removed for evaluation of syncope in patients with suspected extracranial arterial disease
• New criteria address evaluation of TAVR (TAVI) in patients with suspected or established extracranial arterial disease

Myocardial perfusion imaging (MPI), stress echocardiography, cardiac PET, and coronary CT angiography (CCTA)

• Clarifications address exercise-induced syncope and exercise-induced dizziness, lightheadedness or near syncope in symptomatic patients with suspected coronary artery disease

MPI, stress echocardiography, cardiac PET

• Criteria added to allow annual surveillance of coronary artery disease in patients with established CAD post-cardiac transplant
• Clarified definition of established coronary artery disease when diagnosed by CCTA
  • More restrictive for patients diagnosed with coronary artery disease by prior coronary angiography, as FFR must be ≤0.8
  • More permissive for patients diagnosed with coronary artery disease by CCTA with FFR ≤0.8 (patients previously excluded)

Resting transthoracic echocardiography (TTE)

• New criteria for evaluation of ventricular function in patients who have undergone cardiac transplantation.

Cardiac MRI

• New criteria allows for annual study to quantify cardiac iron load in chronically ill patients with cardiomyopathy who require frequent blood transfusions (e.g., thalassemia)
• Removed allowance for annual LV function evaluation when echocardiography is suboptimal

As a reminder, ordering and servicing providers may submit prior authorization requests to AIM in one of several ways:

• Access AIM’s ProviderPortalSM directly at providerportal.com. Online access is available 24/7 to process orders in real-time, and is the fastest and most convenient way to request authorization.
• Access AIM via the Availity Web Portal at availity.com.
• Call the AIM Contact Center toll-free number: 1-800-554-0580, Monday-Friday, 8:30 a.m.-7:00 p.m. ET.

For questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current guidelines on AIM’s website.

Please note, this program does not apply to FEP.

Effective for dates of service on and after January 28, 2019, the following updates will apply to the AIM Specialty Health© (AIM), a separate company, radiation oncology clinical appropriateness guidelines.

Breast cancer

• Removed age and tumor size criteria for accelerated whole breast irradiation (AWBI)

Rectal cancer

• Modified criteria no longer limits treatment with IMRT for rectal adenocarcinoma

Pancreatic cancer

• Added criteria for SBRT in treating locally advanced or recurrent disease without evidence of distant metastasis

Head and neck cancer

• Added criteria to allow IMRT for head and neck lymphomas
• Clarified no IMRT for stage I/II glottic cancer

Lung cancer

• Added DVH parameter for cardiac V50

• Removed preoperative and joint sparing requirements for IMRT

• Added discussion on hypofractionation
• Added discussion on brachytherapy

• Access AIM’s ProviderPortalSM directly at providerportal.com. Online access is available 24/7 to process orders in real-time, and is the fastest and most convenient way to request authorization.
• Access AIM via the Availity Web Portal at availity.com.
• Call the AIM Contact Center toll-free number: 1-800-554-0580, Monday-Friday, 8:30 a.m.-7:00 p.m. ET.

As a reminder, ordering and servicing providers may submit prior authorization requests to AIM in one of several ways:

• Access AIM’s ProviderPortalSM directly at providerportal.com. Online access is available 24/7 to process orders in real-time, and is the fastest and most convenient way to request authorization.
• Access AIM via the Availity Web Portal at availity.com
• Call the AIM Contact Center toll-free number: 1-800-554-0580, Monday-Friday, 8:30 a.m.-7:00 p.m. ET.

For questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current guidelines on AIM’s website.

Please note, this program does not apply to FEP.

Extension for Community Healthcare Outcomes (ECHO)

Opioid overdose rates continue to rise. With the support of MAT ECHO, you can help save lives. Join one of several video tele-consultative ECHO learning communities nationwide and participate with other clinicians learning about medication-assisted treatment for individuals with opioid disorders. For more information, visit the ECHO website.

Benefits of participating include:

• Addiction treatment training.
• Free continuing education credits.
• Opportunity to receive expert input on your (de-identified) patient cases.
• Access to a virtual learning community for treatment guidelines, tools and patient resources.
• Opportunity to ask questions and get a variety of support from specialists.

Quality Medication-Assisted Therapy (MAT)

To help ensure members have access to comprehensive evidence-based care, Anthem is committed to helping its providers double the number of members who receive behavioral health services as part of MAT for opioid addiction.

When treating patients with opioid use disorder, it is considered best practice to offer and arrange evidence-based treatment. This usually consists of MAT with buprenorphine or, in some plans, methadone maintenance treatment in combination with behavioral therapies. Behavioral therapies focused on medication adherence and relapse prevention can improve MAT outcomes and improve other social determinants of health, including development of an enhanced social support network in recovery.

For more information

For more information about best practices for medication-assisted treatment, please read the American Society of Addiction Medicine’s National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.

You can also contact Jennifer Tripp by email at jennifer.tripp@anthem.com for more information about the ECHO and MAT programs.

Sign up to receive immediate notification of new information.

Note that in addition to this newsletter and our website, we also use our email communication, Network eUpdates, to communicate new information.
If you are not yet signed up to receive Network eUpdates, we encourage you to enroll now so you’ll be sure to receive all information that we send about Exchanges. Sign up here.

The AIM Genetic Testing program requires ordering providers to request medical necessity review of all genetic testing services for individual Medicare Advantage members. Requesting this prior authorization will help ensure that the lab receives timely and accurate payment for these services.

Please submit genetic testing prior authorization requests to AIM through one of the following ways:

• Access AIM ProviderPortalSM directly at providerportal.com. Online access is available 24/7 to process orders in real-time, and is the fastest and most convenient way to request authorization.
• Access AIM via the Availity Web Portal at availity.com
• Call the AIM Contact Center toll-free number at 800-714-0040, Monday–Friday, 7 a.m.–7p.m. CT.

For further questions regarding prior authorization requirements, please contact the Provider Services number on the back of your patient’s ID card.

The 2013 American College of Cardiology and the American Heart Association Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults supports the use of moderate-intensity statin therapy in persons with diabetes 40 to 75 years of age to reduce the risks of atherosclerotic cardiovascular disease (ASCVD) events. High-intensity statin therapy is recommended if the patient has an estimated 10-year ASCVD risk greater than or equal to 7.5 percent. For males 21-75 and females 40-75 years of age with clinical ASCVD, high-intensity statin therapy is recommended unless contraindicated.   These guidelines recommend statin therapy in these scenarios regardless of what patient LDL values are.  Please evaluate if your patients with diabetes and/or cardiovascular disease would be appropriate candidates for statin therapy.

Formulary agents are listed below:

Moderate-intensity statin therapy (formulary agents)

High-intensity statin therapy (formulary agents)

*Rosuvastatin (Crestor) is a preferred brand medication on the Medicare formulary. 

**Available for a $0 co-pay for most plans in 2018

Beginning January 1, 2019, Anthem will work with beneficiaries and providers to help to reduce the risk of opioid dependency by streamlining access to opioid medications.  If a beneficiary is exhibiting at-risk opioid medication utilization, the plan sponsor will work with the beneficiary and provider to select a pharmacy home and prescriber home for the beneficiary’s opioid medications.

At risk is defined by CMS as:

1. Greater than 90 mg per day cumulative morphine milligram equivalent (MME)
2. Greater than three (3) opioid prescribers and greater than three (3) opioid dispensing pharmacies, or
3. Greater than five (5) opioid prescribers, regardless of the number of pharmacies

Please note:

• Cancer, LTC and Hospice are exempt
• Beneficiaries will have the choice of which pharmacy or prescriber to select as their home.
• Plan sponsors will request agreement from the provider selected as the home.
• At this time, only opioid and benzodiazepine medications will be delegated to a home pharmacy or prescriber.
• Both beneficiaries and providers will receive letters to explain what is happening and how it will happen.
• Beneficiaries retain the right to request a coverage determination and may choose to change their Home pharmacy or prescriber at any time.

• Prior authorization requirements for Part B drugs: Moxetumomab Pasudotox, Cemiplimab and Fulphila  
• July Medicare Advantage reimbursement policy  
• Submit PA medication requests electronically; new phone number for MA prescription PAs 
• CMS issues regulatory changes for short- and long-acting narcotics; days’ supply limits effective Jan. 1, 2019  
• Inpatient Readmissions  
• CMS issues regulatory changes for short- and long-acting narcotics; days’ supply limits effective Jan. 1, 2019  
• Submit PA medication requests electronically; new phone number for MA prescription prior authorizations effective Sept. 1, 2018 
• Expanded membership now available for prior authorization via ICR

Our solicited medical attachments feature supports an unlimited number of document attachments for each submission and can handle .tiff, .jpg and .pdf attachments. Once your office receives a letter requesting additional documentation, you can send up to 10 attachments through the portal for each claim. The maximum file size is 10 MB per attachment and file sizes larger than 10 MB can be split into smaller ones.

How to access solicited medical attachments for your office

Availity admin, complete these steps:

1. From My Account Dashboard, select Enrollments Center > Medical Attachments Setup, follow the prompts and complete the below sections.
2. Select Application, then choose Medical Attachments Registration.
3. Select Provider Management, then Organization from the drop-down list. Add NPIs and/or tax IDs. Multiples can be added separated by spaces or semicolons.
4. Assign user access by checking the box in front of the user’s name. Users may be removed by unchecking their name.

Using medical attachments

Availity user, complete these steps:

1. Log in to the Availity Portal at https://www.availity.com.
2. Select Claims and Payments > Medical Attachments > Send Attachment.
3. Complete all required fields on the form.
4. Attach supporting documentation.
5. Select Submit.

Need training?

To access additional training for this Availity feature:

1. Log in to the Availity Portal at https://www.availity.com.
2. At the top of any Availity Portal page, choose Help and Training, then Get Trained. Make sure you do not have a pop-up blocker turned on or the next page may not open.
3. In the new window, a list of available topics will open. Locate and select Medical Attachments.
4. Under the Recordings section, select View Recording.

Anthem Blue Cross and Blue Shield (Anthem) would like to remind all Medicaid providers of the requirement to maintain an adequate record keeping system for all books, documents, papers, accounting records, recording services, charges and other information related to health services rendered to members enrolled in Hoosier Healthwise, Healthy Indiana Plan and Hoosier Care Connect. 

As a result of the MegaReg requirements — issued by CMS to update Medicaid managed care regulations — all records must be maintained and, if requested, made available for 10 years from the date of final claim payment (or as required by state and federal regulations).

For detail information on obesity HEDIS® measurements and coding, please view the full update on our provider website.

HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA).

Reminder: Miscellaneous durable medical equipment (DME) procedure codes (such as E1399) cannot be used as an alternative to specific identified codes. Anthem Blue Cross and Blue Shield will conduct post-payment reviews to ensure the right codes for the right services are used. This applies to all claims for Hoosier Healthwise, Healthy Indiana Plan and Hoosier Care Connect members.

In an effort to improve the provider experience, we continually evaluate coding and billing patterns. Recently, we identified trends related to the use of E1399-DME, miscellaneous. This code is only intended for use when a more appropriate code is not available. When an appropriate code does exist, that code must be used regardless of your contracted rate. It is not appropriate to use E1399 for payment increases.

We continue to require prior authorization for the use of miscellaneous code E1399. To request prior authorization, you may use one of the following methods:

• Web: https://www.availity.com
• Fax: 1-866-406-2803 (inpatient — new emergent); 1-844-765-5156 (inpatient — concurrent emergent/new urgent); 1-844-765-5157 (outpatient)
• Phone:
  • Hoosier Healthwise: 1-866-408-6132
  • Healthy Indiana Plan: 1-844-533-1995
  • Hoosier Care Connect: 1-844-284-1798

As it is not our policy to inform providers of proper billing processes within prior authorization responses, authorization responses do not include code-specific details. If your service was approved but your claim was denied payment when billed using E1399, the incorrect code was used. You will need to update the authorization and the claim with the appropriate HIPAA-compliant HCPCS code.

Anthem will conduct post-payment reviews of code E1399 to ensure proper use. If it is determined a more appropriate code should have been used, we will notify you in writing and advise you of your appeal rights.

You can find additional information related to miscellaneous codes in the Unlisted, Unspecified or Miscellaneous Codes reimbursement policy at www.anthem.com/inmedicaiddoc > Prior Authorization & Claims > Reimbursement Policies.

Opioid overdose rates continue to rise. With the medication assisted treatment, you can help save lives! Join one of several video tele-consultative ECHO learning communities nationwide and participate with other clinicians learning about medication-assisted treatment for individuals with opioid disorders. For more information, visit the ECHO website at https://echo.unm.edu.

Benefits of participating include:

• Addiction treatment training.
• Free continuing education credits.
• Opportunity to receive expert input on your (de-identified) patient cases.
• Access to a virtual learning community for treatment guidelines, tools and patient resources.
• Opportunity to ask questions and get a variety of support from specialists.

Quality Medication-Assisted Therapy (MAT)

To help ensure members have access to comprehensive evidence-based care, Anthem is committed to helping its providers double the number of members who receive behavioral health services as part of MAT for opioid addiction.

When treating patients with opioid use disorder, it is considered best practice to offer and arrange evidence-based treatment. This usually consists of MAT with naltrexone, buprenorphine or, in some plans, methadone in combination with behavioral therapies. Behavioral therapies focused on medication adherence and relapse prevention can improve MAT outcomes and improve other social determinants of health, including development of an enhanced social support network in recovery.

For more information

For more information about what is considered best practice for medication-assisted treatment, please read the American Society of Addiction Medicine’s National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.

You can also contact Jennifer Tripp by email at jennifer.tripp@anthem.com for more information about the ECHO and MAT programs.

Members can refer themselves, physicians can refer patients and caregivers can refer patients or family members to case management by calling the number below. They will be connected to a team member based on their immediate needs. Anthem can help with transitions across levels of care in order for patients and caregivers to be better prepared to make health care decisions and meet goals. Members may also be referred to Case Management through:

• Medical Management program referral.
• Discharge planning referral.
• Practitioner referral.
• Member or caregiver referral.

To contact the Case Management department, call 1-866-902-1690 Monday through Friday, 8 a.m. to 5 p.m., ET.

• Drug lists
• Prior authorization criteria
• Procedures for generic substitution
• Step therapy
• Exception requests (Use the forms located on the Pharmacy Benefits page.)
• Other management methods subject to prescribing decisions
• Other requirements, restrictions or limitations that apply to using certain drugs

Information about PDL changes is located under Provider Resources under the Communications & Updates section. For information about copayment/coinsurance requirements and their applicable drug classes, see the Indiana Medicaid Provider Manual listed under Manuals, Directories, Training & More.

If you have questions about this communication or need assistance with any other item, contact your local Provider Relations representative or call Provider Services:

• Hoosier Healthwise — 1-866-408-6132
• Healthy Indiana Plan — 1-844-533-1995
• Hoosier Care Connect — 1-844-284-1798

Effective August 1, 2018, Anthem updated the formulary for asthma controller medications. The table below provides details regarding the new requirements for members:

Preferred spacers for inhalers

Prescribing preferred products helps prevent the need for PA as well as eliminates the inconvenience of denied medications for your patients.

• Call our Pharmacy department and follow the voice prompts for pharmacy PA at:
  • 1-866-408-6132 for Hoosier Healthwise
  • 1‑844‑533‑1995 for Healthy Indiana Plan
  • 1-844-284-1798 for Hoosier Care Connect
• Fax the Pharmacy PA Form (www.anthem.com/inmedicaiddoc / Provider Support / Forms / Pharmacy) and all required information to 1-844-864-7860
• Submit a request using the electronic PA process at https://covermymeds.com